ANXA1 and chronic obstructive pulmonary disease: In addition, COPD patients in GOLD stages III and IV (11.81 ± 1.15) had substantially higher serum levels of annexin A1 than COPD patients in GOLD stages I and II (11.41 ± 0.87, p = 0.002).